Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

NCT02020369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitors
Hemophilia B With Inhibitors

Interventions

BIOLOGICAL: Coagulation Factor VIIa (Recombinant)

Sponsor

rEVO Biologics

Collaborators

[object Object]